Fulcrum Therapeutics Q3'26 Earnings Preview: EPS Estimate $(0.07)
Fulcrum Therapeutics is scheduled to report Q3'26 results on October 29; the release time is unspecified. EPS is estimated at $(0.07).
FULC (Fulcrum Therapeutics, Inc.) is set to announce its Q3'26 results on October 29, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.07) USD. Learn more details at FULC F…